TYR and melanoma: As shown in Figure 5b, the intracellular tyrosinase activity in IBMX-stimulated melanoma was significantly inhibited by DFRB and H, at 106.87 ± 2.32 and 105.63 ± 9.00% of the control (p < 0.05).